A complex pattern of regulation of the cartilage matrix protein gene was revealed by transient expression experiments. A minimal promoter from positions -15 to +64 functioned in chondrocytes and fibroblasts. An enhancer located in the first intron exerted chondrocyte-specific stimulation on the minimal promoter activity. The same fragment, however, had a negative effect in fibroblasts. a Cartilage plays an important role in vertebrate development. Chondrocytes, the cellular components of cartilage, secrete a characteristic set of macromolecules (11). Genes for cartilage proteins are activated in a sequential order concomitant with chondrogenesis (6, 18, 24), indicating the role of both common and distinct regulatory elements in their control. Data are available concerning only the regulation of the type II collagen gene (12, 19) . In an attempt to investigate the molecular events underlying the cartilagespecific gene expression, we isolated genes for chicken link protein (17) and cartilage matrix protein (CMP) (16).
Cartilage plays an important role in vertebrate development. Chondrocytes, the cellular components of cartilage, secrete a characteristic set of macromolecules (11) . Genes for cartilage proteins are activated in a sequential order concomitant with chondrogenesis (6, 18, 24) , indicating the role of both common and distinct regulatory elements in their control. Data are available concerning only the regulation of the type II collagen gene (12, 19) . In an attempt to investigate the molecular events underlying the cartilagespecific gene expression, we isolated genes for chicken link protein (17) and cartilage matrix protein (CMP) (16) .
CMP is a major noncollagenous glycoprotein of hyalin cartilage that forms oligomers via disulfide bridges and may have a function in matrix assembly (1, 22) . The monomer of chicken CMP has a molecular weight of 54,000. The protein consists of two repeated I domains connected by an EGF module, indicating a common evolutionary origin with various protein families (1, 15, 16, 23) .
We have located recently the putative promoter of the CMP gene (16) . To identify cis-acting regulatory regions, selected fragments from the 5' end and the first intron of the gene were coupled to the chloramphenicol acetyltransferase (CAT) reporter gene driven from homologous as well as heterologous promoters. In the names of the constructs, + and -indicate whether the fragment was inserted in the direct or opposite orientation, respectively, relative to the CAT gene. All positions are given in base pairs from the first T of the TATA motif of the CMP gene. Primary chondrocytes were obtained from sterna of 14-day-old chicken embryos. Parallel plates of chondrocyte and fibroblast cultures were transfected with the recombinant clones by the calcium phosphate method (10) and assayed for CAT activity (9) . To correct for the transfection efficiency, parallel plates were also transfected with a control plasmid. The results are expressed as a percentage of the value of CAT activity obtained with the control plasmid (relative CAT activity).
Far-upstream negative regulatory region. fragments of the CMP gene were inserted into the Hindlll site of pTK. CAT (21) . From -10.7 to -2.4 kilobases (kb), no enhancer which was able to increase the expression of the CAT gene driven from the heterologous thymidine kinase (TK) promoter was found (Table 1) . Insertion of HA and HB fragments, however, decreased the promoter activity in chondrocytes by 10-and 5-fold, respectively, in either orientation. The observation that only a moderate inhibition was detected in fibroblasts indicates the presence of chondrocyte-specific negative regulatory elements from 6.8 to 10.7 kb upstream of the CMP gene. Enhancer activity in the first intron. When the 1.2-kb BglII-NcoI fragment carrying the CMP promoter was fused to the CAT reporter gene (Fig. 1) , very low activity was monitored upon transfection of chondrocytes with the parental plasmid pCMP. CAT. N (Fig. 2) . The CAT synthesis decreased even further when fragment B was deleted [pCMP-CAT. N(-B)]. The reason for the weak CMP promoter activity could be either the lack of a tissue-specific enhancer or the presence of a negative regulatory element in the 5'-flanking region of the gene.
In an attempt to find a transcriptional enhancer, we inserted Pa, Pb, Pc, and additional overlapping fragments from the first intron into the CMP promoter-CAT constructs To locate the negative regulatory region, fragments A, B, and C spanning the 5'-flanking region of the CMP gene from positions -1136 to -942, -942 to -334, and -334 to -15, respectively, were removed in different combinations from the parental plasmid ( creased the level of expression compared with that of the parental plasmid. Therefore, we concluded that sequences between -15 and +64 were sufficient to function as a minimal promoter.
In chondrocytes, deletion of fragment C yielded an eightfold increase in CAT activity [compare pCMP-CAT. N(-C) with the parental plasmid]. Even constructs carrying the minimal promoter showed 3-to 12-fold higher levels of CAT synthesis than either of the constructs containing fragment C. The data indicate, therefore, that fragment C harbors a strong negative regulatory element(s).
The presence of fragments A and B stimulated the minimal promoter activity about 2.5-fold in chondrocytes [compare pCMP. CAT. N(-C) with pCMP-CAT. N(-ABC) in Fig. 4 ]. It demonstrates that an upstream positive control region located between -1136 and -334 contributes to the CMP promoter activity.
The intronic Pb fragment, referred to as enhancer in Fig. 3  and 4 , was introduced 5' of the CMP promoter into the members of the deletion series. The construct harboring the enhancer fragment and the minimal promoter gave rise to the highest level of gene expression among the CMP-CAT derivatives in chondrocytes (Fig. 4) . The promoter activity increased up to about 24% of that measured for pSV2-CAT, which carries the strong simian virus 40 enhancer. This finding shows that the stimulation achieved by sequences Modulation of CAT activity by intronic fragments. Construct pCMP. CAT. N(-B) was generated by deleting the Sacl fragment (-942 to -334, fragment B in Fig. 3 ) from the parental plasmid. Pa (+224 to +557) and Pb (+578 to +966) fragments were inserted in both orientations into the PstI site of this plasmid. It is interesting to note that the CMP minimal promoter was about fourfold more active in fibroblasts than in chondrocytes (Fig. 4) . pCMP-CAT. N(-C) displayed the highest level of CAT synthesis in fibroblasts. The 26-fold increase in activity upon removal of fragment C from the parental plasmid indicates that the negative control elements located in fragment C can inhibit the CMP promoter activity even more drastically in fibroblasts than in chondrocytes.
Each of the constructs harboring the enhancer fragment yielded a low level of CAT activity in fibroblasts, and only a slight increase was observed upon insertion of the pb fragment into pCMP-CAT N(-B). To sum up, the Pb fragment conferred positive regulation to the minimal promoter in chondrocytes, while in fibroblasts it repressed the gene expression more than threefold.
None of the constructs depicted in Fig. 3 (Fig. 5) . Therefore, we concluded that the fragment carries a silencer.
The levels of inhibition varied in the given constructs. When inserted in the opposite orientation, fragment C repressed the TK promoter activity by factors of 10 to 65. Upon insertion in the direct orientation, the reduction was 33-fold at position +1783 and less pronounced (3-fold) at positions -223 and -326 [compare derivative Pv2(+) with P19(+) and Pvl(+) in Fig. 5 ]. Further studies are necessary to understand the molecular basis of differences in the silencer activity observed when placed 5' of the promoter.
Either the distance from the TK promoter or the nucleotide sequences surrounding the site of insertion may influence the silencing effect via protein-mediated interactions [compare derivative B9(+) with P19(+) and Pvl(+) in Fig. 5 ]. Nuclease S1 analysis confirmed that insertion of fragment C did not change the initiation site of transcription and that inhibition occurred at the level of transcription (data not shown). Negative regulation was not restricted to chondrocytes. Similar repression was observed in fibroblasts (data not shown).
Fragment C was also inserted into pRSV CAT (8) This observation demonstrates that the silencer is able to interfere with the Rous sarcoma virus enhancer and that the repression is also more pronounced in the opposite than in the direct orientation.
The results reported here identify several blocks of control elements dispersed at the 5' end and in the first intron of the chicken CMP gene which modulate the activity of the minimal promoter. Stimulation was achieved by a region from -1136 to -334 and by a cartilage-specific enhancer residing between +578 and +966. The presence of an pTK CAT (C) FIG. 5. Inhibition of TK promoter activity by fragment C carrying the negative CMP control element. The numbers above the graph indicate the positions where fragment C was inserted into the pTK. CAT vector (+ 1 corresponds to the translation initiation site of the TK gene). In the names of the constructs, insertion sites are denoted as follows: B, BamHI; P, PstI; Pv, PvuII; S, Sall. The ends of fragment C and the Sall and PstI ends were treated with T4 DNA polymerase. BamHI ends were polished with nuclease S1. Clones were verified by sequence analysis. In B4(-), 3 nucleotides were removed 3' of the BamHI cleavage site, while in B9(+), 6 and 9 nucleotides were removed from the vectors upstream and downstream, respectively. Results of four independent transfection experiments in chondrocytes using pTK CAT control are shown.
enhancer in the first intron is also characteristic for the type II collagen and other procollagen genes (12; for a review, see reference 3). The silencer fragment located immediately upstream of the TATA signal inhibited the promoter activity in both chondrocytes and fibroblasts. This finding suggests that the negative factors which bind to the silencer are also present in chondrocytes of 14-day-old chicken embryos. Similarly to the CMP silencer, the r-globin silencer also inhibits its own promoter at the natural position both in erythroid and nonerythroid cell lines (4) .
When the CMP enhancer was inserted upstream of the 1.2-kb CMP promoter fragment, it was not able to override the inhibition caused by the silencer region unless fragment B was deleted (Fig. 5) . One explanation could be that additional, more remote enhancer sequences are also involved in transcriptional control of the gene. Alternatively, disruption of the natural organization of the regulatory elements in the constructs may alter the interactions of these elements with the promoter and with one another, resulting in a low level of gene expression. It has been reported that regulation of human al(I) collagen gene is highly influenced by the geometry of the control elements around the transcriptional start site via protein-mediated promoter-intron interactions (2) .
It is also possible that the CMP promoter or enhancer or both display the highest activity when the gene is turned on in the prechondrogenic limb mesenchymal cells (1, 24) , since the biosynthesis of CMP seems to be suppressed later during differentiation (6) . A correlation between chondrogenesis and the enhancer activity of the rat type II collagen gene was published recently (12) .
The experiments described in this paper provide a basis for the further characterization of the CMP regulatory elements and can promote identification of transacting factors involved in the regulation of cartilage-specific genes.
